| Author (Person) | Rocha, Frederico |
|---|---|
| Publisher | Cardiff EDC |
| Series Details | From November 2017 |
| Publication Date | 15/03/2018 |
| Content Type | News |
|
Further information: The relocation of the European Medicines Agency (EMA) faced difficulties as Italy launched a legal bid to overturn the initial decision in January 2018. + Italy takes EMA relocation decision to the CJEU, January 2018 Background information: The Council of the European Union decided on 20 November 2017 to relocate both agencies to Amsterdam (EMA) and Paris (EBA) in the margins of a meeting of the General Affairs Council (Art.50). The voting was conducted in accordance with the procedure by the European Council summit in June 2017. The relocation of both agencies is a direct consequence of the United Kingdom's decision to leave the European Union, as notified to the European Council on 29 March 2017. It does not form part of the Brexit negotiations and it is subject to discussion between the remaining member states of the European Union. The criteria were set out by European Commission President Jean-Claude Juncker and European Council President Donald Tusk and endorsed by the European Council (in its Article 50 format) on 22 June 2017. A political discussion on this matter was held by the General Affairs Council on 17 October. The European Banking Authority (EBA) works to ensure effective and consistent prudential regulation and supervision across the European banking sector. The European Medicines Agency (EMA) is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU. The European Commission published on 29 November 2017 two legislative proposals to amend the founding Regulations of the European Medicines Agency (EMA) and the European Banking Authority (EBA). + Proposal for a Regulation amending Regulation (EU) No 1093/2010 as regards the location of the seat of the European Banking Authority [COM(2017)734] + Proposal for a Regulation amending Regulation (EC) No 726/2004 as regards the location of the seat of the European Medicines Agency [COM(2017)735] The European Parliament endorsed the relocation of the European Medicines Agency on 15 March 2018, subject to conditions. |
|
| Related Links |
|
| Subject Categories | Politics and International Relations |
| Countries / Regions | Europe |
